PLAY PODCASTS
The Prior Authorization Crisis and 340B Drug Program Explained
Episode 276

The Prior Authorization Crisis and 340B Drug Program Explained

Healthcare Americana · Christopher Habig

December 9, 202536m 17s

Audio is streamed directly from the publisher (pdcn.co) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode of Healthcare Americana, host Christopher Habig talks with neurosurgeon and healthcare policy leader Dr. Anthony DiGiorgio about the growing crisis around prior authorizations. They discuss how complicated approval processes delay urgent care, burden physicians, and put patients at risk. Dr. DiGiorgio explains why smarter, low-friction models such as gold-carding and stronger subspecialty board oversight could help rebuild trust between physicians and payers. The conversation also covers the 340B drug discount program, which Dr. DiGiorgio has testified about before Congress. He explains how a program originally designed to help low-income patients has become a major revenue source for large hospital systems and often increases costs for Medicaid, Medicare, and private insurance. Together, they offer a clear and accessible look at what is broken in these systems and what meaningful reform could achieve.

More on Freedom Healthworks & FreedomDoc Health

Subscribe at https://healthcareamericana.com/

More on Dr. Anthony DiGiorgio

Follow Healthcare Americana: Instagram & LinkedIN